A new tool for understanding ALS: Patients' brain cells

(Johns Hopkins Medicine) Researchers at Johns Hopkins Medicine have transformed skin cells from patients with Lou Gehrig's disease, or amyotrophic lateral sclerosis (ALS), into brain cells affected by the progressive, fatal disease, and have deposited those human-made cells into the first public ALS cell library, enabling scientists to better study the disease.